Publications

Export 94 results:
Sort by: Author Title Type [ Year  (Desc)]
2023
N.S, S., H. Zedan, A. Hesham, M. Fawz, E. Diab, A. S. Yassin, and M. Abu-Elghait, "Advanced approaches for endotoxin detection and removal from snake antivenoms.", Toxicon, vol. 222, pp. 107003, 2023.
Aboulwafa, M., R. Hassan, M. Abdel-Hakeem, and H. Zedan, "Etanercept and Infliximab, two tumor necrosis factor-α (TNF-α) inhibitors with different action profiles: An in vitro and in vivo study in the context of reviewed therapeutic applications.", Biointerface Research in Applied Chemistry , vol. 13, pp. 309, 2023.
Hassan, S. T., H. Zedan, A. F. Mohamed, and N. H. Abdallah, "Evaluation of MMR live attenuated vaccine oncolytic potential using Ehrlich ascites carcinoma in a murine model.", Medical Oncology , 2023.
R., B., A. Gaber, H. Zedan, and M. Mabrook, "New typhoid vaccine using sponge-like reduced protocol: development and evaluation.", Clin Exp Vaccine Res , vol. 12, pp. 70-76, 2023.
R, E., H. Zedan, T. H. Elmorsy, and R. A. Khattab, "Prevalence and in- vivo assessment of virulence in Shiga Toxin-Producing Escherichia coli clinical isolates from Greater Cairo Area", Microbial Drug Resistance , 2023.
2022
Abulmagd, S., A. A. Khattab, and H. Zedan, "Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.", Clin Exp Vaccine Res, vol. 11, issue 1, pp. 12-29, 2022.
Taha, A. M., M. M. Aboulwafa, H.Zedan, and O. M. Helmy, "Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells.", Scientific Reports, vol. 12:, pp. 17889, 2022.
2021
Omar, S., H. H. Zedan, and M. T. Ibrahim, "Quorum sensing inhibitory effect of bergamot oil and aspidosperma extract against Chromobacterium violaceum and Pseudomonas aeruginosa.) 203:4663–4675", Archives of Microbiology , issue 203, pp. 4663–4675 , 2021.
Elshimy, R., H. Zedan, H. E. Tarek, and R. A. Khattab, "A study on multidrug-resistant E. coli clinical isolates from greater Cairo area hospitals.", Microbial Drug Resistance , vol. 27, issue 10, pp. 1420-1432, 2021.
Kilany, L. A., A. A. Gaber, M. M. Aboulwafa, and H. H. Zedan, "Therapeutic Monoclonal Antibodies: Future Prospectives", J Cancer Immunol. , vol. 3, issue 4, pp. 177-182, 2021.
Kilany, L. A., A. A. Gaber, M. M. Aboulwafa, and H. H. Zedan, "Trastuzumab immunogenicity development in patients’ sera and in laboratory animals", BMC Immunology, vol. 23, issue 1, pp. 1-15, 2021.
2020
Sheraba, N. S., A. S. Yassin, M. R. Diab, M. A. Amin, Y. Alhamhoom, and H. H. Zedan, "An Efficient Method for Endotoxin Removal from Snake Antivenoms: A Comparative Study of Different Chromatography Techniques.", Chromatographia, vol. 83, pp. 779–787 , 2020.
Korany, E. S., O. M. Helmy, E. A. M. Halawany, Y. E. Ragab, and H. H. Zedan, "Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate", BMC Biotechnology , vol. 20, issue 1, pp. 1-16, 2020.
2019
Nabi, E. H. A., N. A. Saleh, and H. Zedan, "Correlation of efflux pumps expression in carbapenem resistance Acinetobacter baumannii: Synthetic and natural efflux pump inhibitors as therapy approach.", ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, Boston, USA, 3 September, 2019.
Sheraba, N. S., A.S.Yassin, M. R. Diab, M. A. Amin, and H. H. Zedan, "A Validation study of the Limulus Amebocyte Lysate test as end-product endotoxin test for polyvalent horse snake antivenom.", PDA J Pharm Sci Technol., vol. 73, issue 6, pp. 562-571, 2019.
2018
Helal, H. S., A. Hanora, R. A. Khattab, H. Hamouda, and H. H. Zedan, "Mining of Egypt’s Red Sea invertebrates for potential bioactive producers.", Biotechnology Letters , vol. 40, issue 11-12, pp. 1519-1530, 2018.
Elshimy, R., R. A. Khattab, H. Zedan, A.S.Hosny, and M. Tarek, "Study on prevalence and genetic discrimination of methicillin-resistant Staphylococcus aureus (MRSA) in Egyptian hospitals", Afr. J. Microbiol. Res. , vol. 12, issue 27, pp. 629 – 646., 2018.
2017
Ghattas, M. Z., M. T. ElRakaiby, R. K. Aziz, and H. H. Zedan, "Staphostatins as genetic biomarkers to differentiate Staphylococcus aureus from Staphylococcus epidermidis in clinical isolates and nasal microbiome samples.", 16th Annual UT-KBRIN Bioinformatics Summit , Burns, TN, USA, BMC Proc 11, 9 (2017), pp. 9, 2017.
2016
Abdeldayem, S. A., H. Zedan, A. Badr, A. Fahmy, and M. Akmal, "In vitro evaluation of anticancer activity of 5-fluorouracil and curcumin in single and combined forms against breast and colon cancer cell lines. ", International Journal of Advanced Research , vol. 4, issue 6, pp. 1649-1657, 2016.
2015
Sheraba, N. S., A. S. Yassin, M. R. Diab, and H. H. Zedan, "Quality control testing for tracking endotoxin producing Gram negative bacteria during ‎the preparation of polyvalent snake antivenom immunoglobulin. ‎", PDA J.Pharm.Sci.Tech. , vol. 69, pp. 499-510, 2015.
Aboleil, A., and H. Zedan, "Synthesis, cloning and expression of a novel pre-‎miniproinsulin analogue gene in Escherichia coli.", Journal of Advanced Research , vol. 6, pp. 663-673, 2015.
2014
Zedan, H., Overview of Egypt’s Biodiversity Status and Trends. Report for EEAA, Egyptian Ministry of the Environment, , Cairo, EEAA, Egyptian Ministry of the Environment, Egypt, pp. 259, August, 2014.
Salem, M. H., G. G. Zhanel, H. Zedan, and A. M. Noreddin, "Evaluation of Telavancin, Daptomycin, Tigecycline, Linezolid, and Vancomycin Pharmacodynamics against MRSA Isolates Collected in the Canadian-Ward (CAN-Ward) Surveillance Study: A Monte Carlo Simulation Analysis. ", The American Association of Pharmaceutical Scientists Annual Meeting, San Diego, California, USA., 3 November, 2014.
Tourism